{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T14:38:39Z","timestamp":1721659119176},"reference-count":42,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.2967\/jnumed.109.073585","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T03:52:16Z","timestamp":1279770736000},"page":"1285-1292","source":"Crossref","is-referenced-by-count":8,"title":["Small-Animal PET\/CT for Monitoring the Development and Response to Chemotherapy of Thymic Lymphoma in <i>Trp53<\/i><sup>\u2212\/\u2212<\/sup> Mice"],"prefix":"10.2967","volume":"51","author":[{"given":"Martin A.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel J.","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Hacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam L.","family":"Kesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory W.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Schiestl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2010,7,21]]},"reference":[{"key":"2021051712004461000_51.8.1285.1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese","year":"2007","journal-title":"Nat Rev Cancer."},{"key":"2021051712004461000_51.8.1285.2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0482"},{"key":"2021051712004461000_51.8.1285.3","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.1998.16.9.3158","article-title":"Tumor-suppressor p53: implications for tumor development and prognosis","volume":"16","author":"Kirsch","year":"1998","journal-title":"J Clin Oncol."},{"key":"2021051712004461000_51.8.1285.4","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 in hematologic malignancies","volume":"84","author":"Imamura","year":"1994","journal-title":"Blood."},{"key":"2021051712004461000_51.8.1285.5","doi-asserted-by":"publisher","DOI":"10.1038\/35042675"},{"key":"2021051712004461000_51.8.1285.6","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood."},{"key":"2021051712004461000_51.8.1285.7","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood."},{"key":"2021051712004461000_51.8.1285.8","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood.V86.12.4587.bloodjournal86124587","article-title":"The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma","volume":"86","author":"Du","year":"1995","journal-title":"Blood."},{"key":"2021051712004461000_51.8.1285.9","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood."},{"key":"2021051712004461000_51.8.1285.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2009"},{"key":"2021051712004461000_51.8.1285.11","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000226"},{"key":"2021051712004461000_51.8.1285.12","doi-asserted-by":"publisher","DOI":"10.1038\/356215a0"},{"key":"2021051712004461000_51.8.1285.13","first-page":"3313","article-title":"Enhanced proliferative potential in culture of cells from p53-deficient mice","volume":"8","author":"Tsukada","year":"1993","journal-title":"Oncogene."},{"key":"2021051712004461000_51.8.1285.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(00)00002-6"},{"key":"2021051712004461000_51.8.1285.15","first-page":"603","article-title":"Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene","volume":"9","author":"Purdie","year":"1994","journal-title":"Oncogene."},{"key":"2021051712004461000_51.8.1285.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2004.08.022"},{"key":"2021051712004461000_51.8.1285.17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90201-1"},{"key":"2021051712004461000_51.8.1285.18","doi-asserted-by":"publisher","DOI":"10.1038\/35006670"},{"key":"2021051712004461000_51.8.1285.19","doi-asserted-by":"publisher","DOI":"10.1038\/nm1320"},{"key":"2021051712004461000_51.8.1285.20","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0704-565"},{"key":"2021051712004461000_51.8.1285.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-097238"},{"key":"2021051712004461000_51.8.1285.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0861"},{"key":"2021051712004461000_51.8.1285.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.10.036"},{"key":"2021051712004461000_51.8.1285.24","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1724"},{"key":"2021051712004461000_51.8.1285.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404396101"},{"key":"2021051712004461000_51.8.1285.26","unstructured":"Guide for the Care and Use of Laboratory Animals. Bethesda, MD: National Institutes of Health; 1985. NIH publication 85-23."},{"key":"2021051712004461000_51.8.1285.27","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-008-0165-0"},{"key":"2021051712004461000_51.8.1285.28","doi-asserted-by":"publisher","DOI":"10.1162\/153535003322556877"},{"key":"2021051712004461000_51.8.1285.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363982"},{"key":"2021051712004461000_51.8.1285.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2007.04.004"},{"key":"2021051712004461000_51.8.1285.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813210106"},{"key":"2021051712004461000_51.8.1285.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-008-0137-4"},{"key":"2021051712004461000_51.8.1285.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2007.10.003"},{"key":"2021051712004461000_51.8.1285.34","doi-asserted-by":"publisher","DOI":"10.1080\/10428190801911704"},{"key":"2021051712004461000_51.8.1285.35","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2002.n.015"},{"key":"2021051712004461000_51.8.1285.36","doi-asserted-by":"publisher","DOI":"10.1038\/35094077"},{"key":"2021051712004461000_51.8.1285.37","first-page":"1193","article-title":"In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy","volume":"60","author":"Rogulski","year":"2000","journal-title":"Cancer Res."},{"key":"2021051712004461000_51.8.1285.38","first-page":"500","article-title":"Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications","volume":"1","author":"Horowitz","year":"1999","journal-title":"Curr Opin Mol Ther."},{"key":"2021051712004461000_51.8.1285.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00206.x"},{"key":"2021051712004461000_51.8.1285.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.05.041"},{"key":"2021051712004461000_51.8.1285.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01139-2"},{"key":"2021051712004461000_51.8.1285.42","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006140513233"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.109.073585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:26:38Z","timestamp":1621279598000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.109.073585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,21]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,2]]},"published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.2967\/jnumed.109.073585"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.109.073585","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,21]]}}}